Alembic reports 11 per cent growth in revenue for Q4 FY22 from Rs 1,280 crores in FY21 to Rs 1,416 crores Read more
Aleor Dermaceuticals receives US FDA final approval for Nystatin and Triamcinolone Acetonide Ointment Read more